Thesis icon

Thesis

Quantitative proteomics to unravel NLRP3 inflammasome biology

Abstract:
Inflammasomes are multi-protein complexes that serve as critical sensors to fend off pathogens and resolve aberrant cellular physiology. The NOD-, LRR-, and Pyrin domain-containing 3 (NLRP3) inflammasome can detect a wide range of stimuli, including pathogen-associated molecular patterns (PAMPs), damage-associated molecular patterns (DAMPs), and homeostasis-altering molecular processes (HAMPs). It drives the production of pro-inflammatory cytokine interleukin-1β (IL-1β) through the caspase-1 dependent signalling pathway. Despite extensive studies, no consensus model for the activation mechanism exists. Thus, systematic interrogation of NLRP3 inflammasome activation is highly desirable. Emerging mass spectrometry (MS) methodologies and proteomics have enabled the comprehensive mapping of intracellular protein networks. In this thesis, multiple MS-based strategies have been utilised to examine the global perturbation during NLRP3 inflammasome priming and activation. Using multiplexed TMT-based proteomics and di-Gly ubiquitomics, we presented a high-resolution map of proteome and ubiquitome profiles in THP-1 cells in response to NLRP3 activators. Through the combination of co-fractionation mass spectrometry (CF-MS) and machine learning algorithms, we elucidated the spatial and subcellular proteomic changes during the NLRP3 inflammasome activation process. We observe substantial relocalisation of the complex upon stimulation. Furthermore, utilising the APEX2 proximity labelling (PL)-MS approach, we spatiotemporally characterized the “proximity proteome (also known as proximitome)” of the NLRP3 inflammasome. Combined with RNAi screening, two NLRP3-interacting proteins, USP10 and UCHL1, were identified and validated as essential regulators for NLRP3 activation downstream of potassium efflux. Collectively, the MS-based approaches, including multiplexed proteomics, di-Gly ubiquitomics, CF-MS, and APEX2 PL-MS, enable a comprehensive understanding of the NLRP3 inflammasome activation process. These new insights into the underlying mechanism provide potential novel therapeutic targets, which may ultimately lead to treatments for NLRP3-associated diseases.

Actions


Authors


More by this author
Division:
MSD
Department:
NDM
Sub department:
Target Discovery Institute
Oxford college:
Exeter College
Role:
Author

Contributors

Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Target Discovery Institute
Role:
Supervisor
Role:
Supervisor
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Kennedy Institute for Rheumatology
Role:
Examiner
Role:
Examiner


More from this funder
Funder identifier:
http://dx.doi.org/10.13039/501100004543
Funding agency for:
Liang, Z
Programme:
CSC-CAMS/PUMC-Oxford High-level Innovative Talent Scholarships


Type of award:
DPhil
Level of award:
Doctoral
Awarding institution:
University of Oxford

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP